ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
5.956,68
0,44%
Dow Jones
42.789,94
-0,12%
Euro vs US Dollar
1,04054
-0,26%
Bitcoin
92.935,46
-2,29%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Indivior PLC (INDV) Börsenkurse

Indivior PLC

Indivior PLC (INDV)

Indivior Plc
11,83
0,17
( 1,46% )
Aktualisiert: 20:35:53
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
11,83
Gebot
11,81
Fragen
11,83
Volumen
162.834
11,75 Tagesbereich 11,90
7,33 52-Wochen-Bereich 23,22
Marktkapitalisierung
1,533B
Handelsende
11,66
Handelsbeginn
11,80
Letzte Trade
2
@
11.817
Letzter Handelszeitpunkt
20:38:00
Finanzvolumen
US$ 1.925.838
VWAP
11,827
Durchschnittliches Volumen (3 Mio.)
1.305.464
Ausgegebene Aktien
129.575.205
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
613,64
Gewinn pro Aktie (EPS)
0,02
Erlöse
1,09B
Nettogewinn
2M

Über Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by... Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.indivior.com
Hauptsitz
Berkshire, Gbr
Gegründet
-
Indivior PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker INDV. The last closing price for Indivior was US$11,66. Over the last year, Indivior shares have traded in a share price range of US$ 7,33 to US$ 23,22.

Indivior currently has 129.575.205 shares in issue. The market capitalisation of Indivior is US$1,51 billion. Indivior has a price to earnings ratio (PE ratio) of 613.64.

INDV Neueste Nachrichten

Weitere Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

2 Stunden vor
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

18 Dezember 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Dezember 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Dezember 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 Dezember 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

03 Dezember 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

02 Dezember 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 November 2024
Edgar (US Regulatory)

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM...

19 November 2024
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.151.2842465753411.6812.199911.2809134403511.70339125CS
40.978.9318600368310.8612.199910.62127418811.47510604CS
121.919.13393756299.9312.19997.3313054649.99030264CS
26-4.54-27.733659132616.3716.697.33105282410.53004391CS
52-3.35-22.068511198915.1823.227.3358696211.28779135CS
156-14.67-55.35849056626.526.57.3338651011.42112515CS
260-14.67-55.35849056626.526.57.3338651011.42112515CS

INDV - Frequently Asked Questions (FAQ)

What is the current Indivior share price?
The current share price of Indivior is US$ 11,83
How many Indivior shares are in issue?
Indivior has 129.575.205 shares in issue
What is the market cap of Indivior?
The market capitalisation of Indivior is USD 1,51B
What is the 1 year trading range for Indivior share price?
Indivior has traded in the range of US$ 7,33 to US$ 23,22 during the past year
What is the PE ratio of Indivior?
The price to earnings ratio of Indivior is 613,64
What is the cash to sales ratio of Indivior?
The cash to sales ratio of Indivior is 1,12
What is the reporting currency for Indivior?
Indivior reports financial results in USD
What is the latest annual turnover for Indivior?
The latest annual turnover of Indivior is USD 1,09B
What is the latest annual profit for Indivior?
The latest annual profit of Indivior is USD 2M
What is the registered address of Indivior?
The registered address for Indivior is 234 BATH ROAD, SLOUGH, BERKSHIRE, SL1 4EE
What is the Indivior website address?
The website address for Indivior is www.indivior.com
Which industry sector does Indivior operate in?
Indivior operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DRCTDirect Digital Holdings Inc
US$ 3,82
(594,55%)
49,22M
CHEKCheck Cap Ltd
US$ 2,18
(269,49%)
29,42M
RELIReliance Global Group Inc
US$ 3,10
(158,33%)
100,34M
TRAWTraws Pharma Inc
US$ 12,3801
(146,62%)
26,81M
RAPTRAPT Therapeutics Inc
US$ 1,7007
(106,05%)
129,24M
AILEiLearningEngines Inc
US$ 0,2431
(-72,53%)
19,41M
MGOLMGO Global Inc
US$ 0,4634
(-51,22%)
12,45M
YHCLQR House Inc
US$ 1,0774
(-38,43%)
1,17M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4011
(-34,42%)
153,39M
ADGMAdagio Medical Holdings Inc
US$ 1,125
(-31,82%)
4,51M
EDBLEdible Garden AG Inc
US$ 0,3809
(60,24%)
387,53M
RGTIRigetti Computing Inc
US$ 11,0712
(18,16%)
198,95M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4011
(-34,42%)
153,39M
RIMEAlgorhythm Holdings Inc
US$ 0,0921
(20,55%)
134,08M
RAPTRAPT Therapeutics Inc
US$ 1,7007
(106,05%)
128,7M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
INDV
Indivior
TG
6LJ
Matinas Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten